» Articles » PMID: 25267416

A Microsoft-Excel-based Tool for Running and Critically Appraising Network Meta-analyses--an Overview and Application of NetMetaXL

Overview
Journal Syst Rev
Publisher Biomed Central
Date 2014 Oct 1
PMID 25267416
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The use of network meta-analysis has increased dramatically in recent years. WinBUGS, a freely available Bayesian software package, has been the most widely used software package to conduct network meta-analyses. However, the learning curve for WinBUGS can be daunting, especially for new users. Furthermore, critical appraisal of network meta-analyses conducted in WinBUGS can be challenging given its limited data manipulation capabilities and the fact that generation of graphical output from network meta-analyses often relies on different software packages than the analyses themselves.

Methods: We developed a freely available Microsoft-Excel-based tool called NetMetaXL, programmed in Visual Basic for Applications, which provides an interface for conducting a Bayesian network meta-analysis using WinBUGS from within Microsoft Excel. . This tool allows the user to easily prepare and enter data, set model assumptions, and run the network meta-analysis, with results being automatically displayed in an Excel spreadsheet. It also contains macros that use NetMetaXL's interface to generate evidence network diagrams, forest plots, league tables of pairwise comparisons, probability plots (rankograms), and inconsistency plots within Microsoft Excel. All figures generated are publication quality, thereby increasing the efficiency of knowledge transfer and manuscript preparation.

Results: We demonstrate the application of NetMetaXL using data from a network meta-analysis published previously which compares combined resynchronization and implantable defibrillator therapy in left ventricular dysfunction. We replicate results from the previous publication while demonstrating result summaries generated by the software.

Conclusions: Use of the freely available NetMetaXL successfully demonstrated its ability to make running network meta-analyses more accessible to novice WinBUGS users by allowing analyses to be conducted entirely within Microsoft Excel. NetMetaXL also allows for more efficient and transparent critical appraisal of network meta-analyses, enhanced standardization of reporting, and integration with health economic evaluations which are frequently Excel-based.

Citing Articles

Risk of Cardiovascular Events with Cyclin-Dependent Kinases 4 and 6 (CDK 4/6) Inhibitors among Patients with Advanced Breast Cancer: A Systematic Review and Network Meta-Analysis.

Liu Y, Dong K, Park C Rev Cardiovasc Med. 2024; 24(11):309.

PMID: 39076428 PMC: 11262445. DOI: 10.31083/j.rcm2411309.


Comparison of target agent treatment strategies for platinum-resistant recurrent ovarian cancer: A Bayesian network meta-analysis.

Leung J, Leung H, Wang S, Yip Fion H, Chan A Medicine (Baltimore). 2024; 103(21):e38183.

PMID: 38788019 PMC: 11124750. DOI: 10.1097/MD.0000000000038183.


Comparison of interventions for Barrett's esophagus: A network meta-analysis.

Zhang Q, Li M, Jin X, Zhou R, Ying Y, Wu X PLoS One. 2024; 19(5):e0302204.

PMID: 38709808 PMC: 11073690. DOI: 10.1371/journal.pone.0302204.


Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.

Huan L, Yu F, Cao D, Zhou H, Qin M, Cao Y PLoS One. 2024; 19(3):e0295983.

PMID: 38451955 PMC: 10919605. DOI: 10.1371/journal.pone.0295983.


Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis.

Leung J, Wang S, Leung H, Chan A Front Oncol. 2024; 14:1344798.

PMID: 38434681 PMC: 10905023. DOI: 10.3389/fonc.2024.1344798.


References
1.
Jones B, Roger J, Lane P, Lawton A, Fletcher C, Cappelleri J . Statistical approaches for conducting network meta-analysis in drug development. Pharm Stat. 2012; 10(6):523-31. DOI: 10.1002/pst.533. View

2.
Nikolakopoulou A, Chaimani A, Veroniki A, Vasiliadis H, Schmid C, Salanti G . Characteristics of networks of interventions: a description of a database of 186 published networks. PLoS One. 2014; 9(1):e86754. PMC: 3899297. DOI: 10.1371/journal.pone.0086754. View

3.
Turner R, Davey J, Clarke M, Thompson S, Higgins J . Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol. 2012; 41(3):818-27. PMC: 3396310. DOI: 10.1093/ije/dys041. View

4.
Dias S, Welton N, Sutton A, Caldwell D, Lu G, Ades A . Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making. 2013; 33(5):641-56. PMC: 3704208. DOI: 10.1177/0272989X12455847. View

5.
Dias S, Sutton A, Ades A, Welton N . Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2012; 33(5):607-17. PMC: 3704203. DOI: 10.1177/0272989X12458724. View